Discover how cell-free DNA sequencing and whole-body MRI provide a breakthrough in detecting occult cancers in pregnant women.
Vous n'êtes pas connecté
Highlights: Nearly 50% of pregnant women with abnormal cfDNA results had undiagnosed occult cancers Whole-body M
Discover how cell-free DNA sequencing and whole-body MRI provide a breakthrough in detecting occult cancers in pregnant women.
Cell-free DNA (cfDNA) is one of the important biomarkers of liquid biopsy for many malignant cancers like urothelial bladder cancer. However, the
In the 2024 MITRE ATT&CK® Evaluations, Check Point demonstrated what world-class detection looks like. The results speak for themselves: detection of...
MONDAY, Dec. 16, 2024 -- The established hormone therapy drug tamoxifen can significantly decrease the risk of cancer recurring in women with an...
FRIDAY, Dec. 13, 2024 -- An experimental hormone therapy pill has shown promise in extending the lives of women with tough-to-treat advanced breast...
FRIDAY, Dec. 13, 2024 -- An experimental hormone therapy pill has shown promise in extending the lives of women with tough-to-treat advanced breast...
Highlights: Proton beam therapy targets glioblastoma with fewer side effects About 56% of patients survived 12 m
Diabetes during pregnancy? Don't let undiagnosed gestational diabetes put your pregnancy at risk. Faster blood processing could save thousands of...
TUESDAY, Dec. 10, 2024 -- More breast cancers are being detected later in women, giving the tumors a chance to spread and become life-threatening, a...
Learn how donor-derived cell-free DNA (dd-cfDNA) offers a minimally invasive, sensitive approach for early detection of graft issues, reducing...